Antibiogo : The project is presented in The Good AI magazine
Share
Share on Facebook
Share on Telegram
Share on LinkedIn
Share on Twitter
Copy link
Page url is copied
This article in The Good AI about Antibiogo is very clear... or how to understand in 5 minutes the essence of our approach! "This is AI for Good at its best".
The author analyzes the reasons for the success of the project (which will enter its final phase of clinical trials) and discusses, among other things, the MSF Foundation as an assembler of collective intelligence at the service of a need. Definitely a must read.
The MSF Foundation is innovating by adapting a tool to help healthcare workers manage diabetic ketoacidosis, a severe acute complication in children with diabetes.
In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated...
